首页 › 非小细胞肺癌 › 康涅狄格州 › Hartford
Hartford CT 非小细胞肺癌临床试验
12项针对 非小细胞肺癌的研究正在 Hartford及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
招募中3 期
- Smilow Cancer Hospital Care Center at Saint Francis, Hartford
A Clinical Study of Calderasib (MK-1084) and Other Treatments for Participants With Non-Small Cell Lung Cancer (MK-1084-007/KANDLELIT-007)
招募中3 期
- University of Connecticut Health Center ( Site 0130), Farmington · 距离 8 英里
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
招募中3 期
- Hartford Hospital, Hartford
- Hartford HealthCare - Avon, Avon · 距离 8 英里
- Hartford HealthCare - Manchester, Manchester · 距离 8 英里
- 以及另外 1 项
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
招募中3 期
- Hartford Hospital (HH), Hartford
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
招募中3 期
- Hartford Hospital, Hartford
A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
招募中1/2 期
- Hartford Healthcare, Hartford
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
招募中2 期
- Smilow Cancer Hospital Care Center at Saint Francis, Hartford
- Smilow Cancer Hospital Care Center at Glastonbury, Glastonbury · 距离 5 英里
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
招募中2/3 期
- Smilow Cancer Hospital Care Center at Saint Francis, Hartford
- Smilow Cancer Hospital Care Center at Glastonbury, Glastonbury · 距离 5 英里
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
招募中2 期
- Smilow Cancer Hospital Care Center at Saint Francis, Hartford
- Smilow Cancer Hospital Care Center at Glastonbury, Glastonbury · 距离 5 英里
Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease
招募中2 期
- Hartford Healthcare, Hartford
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
招募中1/2 期
- Hartford Hospital (site 210), Hartford
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
招募中观察性研究
- Massive Bio SYNERGY-AI site, Hartford
其他城市的 非小细胞肺癌试验
- Houston, TX145 项研究
- New York City, NY121 项研究
- Arlington, VA104 项研究
- Nashville, TN97 项研究
- Boston, MA90 项研究
- Los Angeles, CA87 项研究
- St. Louis, MO73 项研究
- Chicago, IL61 项研究
- Baltimore, MD60 项研究
- San Antonio, TX59 项研究
- Columbus, OH57 项研究
- Washington, DC55 项研究
Hartford的其他研究
- 肺癌11 项研究
- 重度抑郁症9 项研究
- 癌症（所有类型）9 项研究
- 乳腺癌9 项研究
- 神经母细胞瘤8 项研究
- 多发性骨髓瘤7 项研究
- 心力衰竭7 项研究
- 前列腺癌7 项研究
- 卵巢癌7 项研究
- 心血管疾病7 项研究
- 胰腺癌7 项研究
- 子宫内膜癌5 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。